TWiV 1084: Clinical update with Dr. Daniel Griffin episode artwork

EPISODE · Feb 3, 2024 · 44 MIN

TWiV 1084: Clinical update with Dr. Daniel Griffin

from This Week in Virology · host Vincent Racaniello

In his weekly clinical update, Dr. Griffin discusses the how the pandemic influenced the healthcare job market before he reviews most recent statistics on the circulation of respiratory syncytial virus, influenza virus and SARS-CoV-2 virus, including all circulating variants in the US, discusses the safety of the prefusion RSV vaccine, if high or moderate dose of the quadrivalent influenza vaccine is better for protection against hospitalization, summarizes the new WHO COVID guidelines, revisits how to prevent pathogen transmission in healthcare setting, the under use of COVID oral antiviral and what occurs in persistently SARS-CoV-2 infected cells in culture after antiviral treatment, continues to dispel the myth of viral rebound, how to pay for paxlovid, when to use steroids and the benefits of convalescent plasma, how inflammatory markers change correlate with death when in ICU and if cognitive slowing is part of long COVID-19. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Do you want a job in healthcare? (JAMA) Respiratory  disease surveillance (CDC) RSV surveillance  (CDC) RSV national trend (CDC) Efficacy and safety of RSV vaccine after 2 seasons (CID) High vs moderate dose of quadrivalent influenza vaccine (CMI) Influenza/flu surveillance  (CDC) Influenza/flu map (CDC) COVID-19  hospital admissions (CDC) COVID-19 national trend (CDC) COVID-19 wastewater testing (biobot) Variant tracker (CDC) Variant hospital admissions (CDC) WHO COVID guidance (WHO) Thoughts on COVID guidance (CIDRAP) Update on how to prevent pathogen transmission in healthcare settings (CDC) Underuse of antiviral drugs against COVID-19 (MMWR) Revisiting tissue culture cells persistently infected following antiviral therapy (bioRxiv) To rebound or to not rebound (MMWR) Know your COVID-19 tools (ESMED) How to pay for Paxlovid (PAXCESS) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (IDSociety) Steroids,dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Changes in inflammatory markers and death correlation when in ICU (Cytokine) Long COVID & cognitive slowing? (eClinicalMedicine)   Contribute to our ASTMH fundraiser at PWB Letters read on TWiV 1084 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]

Episode metadata supplied by the publisher feed · Published Feb 3, 2024

Embed this episode

NOW PLAYING

TWiV 1084: Clinical update with Dr. Daniel Griffin

0:00 44:08

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of This Week in Virology?

This episode is 44 minutes long.

When was this This Week in Virology episode published?

This episode was published on February 3, 2024.

Can I download this This Week in Virology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!